|
ARL6IP6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6350000242582E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.92839996696159E-09 |
| Normal-vs-Stage2 |
5.035300E-04 |
| Normal-vs-Stage3 |
1.7941799999921E-05 |
| Normal-vs-Stage4 |
6.10599999999462E-05 |
| Stage1-vs-Stage2 |
6.819000E-01 |
| Stage1-vs-Stage3 |
3.022400E-01 |
| Stage1-vs-Stage4 |
8.854600E-01 |
| Stage2-vs-Stage3 |
3.549000E-01 |
| Stage2-vs-Stage4 |
6.449200E-01 |
| Stage3-vs-Stage4 |
5.488600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70260000437383E-09 |
| Normal-vs-AfricanAmerican |
4.824700E-04 |
| Normal-vs-Asian |
1.489630E-02 |
| Caucasian-vs-AfricanAmerican |
6.364200E-01 |
| Caucasian-vs-Asian |
1.346070E-02 |
| AfricanAmerican-vs-Asian |
1.008130E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.90919963066949E-10 |
| Normal-vs-Female |
3.32690000004465E-06 |
| Male-vs-Female |
5.684400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.318000E-03 |
| Normal-vs-Age(41-60Yrs) |
6.25630003359134E-09 |
| Normal-vs-Age(61-80Yrs) |
4.39589999956524E-08 |
| Normal-vs-Age(81-100Yrs) |
5.945700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.193200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.407600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.662800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.132400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.715800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.003800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.432970E-04 |
| Normal-vs-Grade 2 |
5.26499954744963E-10 |
| Normal-vs-Grade 3 |
3.50600000031953E-07 |
| Normal-vs-Grade 4 |
1.699570E-03 |
| Grade 1-vs-Grade 2 |
6.609200E-01 |
| Grade 1-vs-Grade 3 |
1.118790E-01 |
| Grade 1-vs-Grade 4 |
3.271000E-01 |
| Grade 2-vs-Grade 3 |
2.413900E-02 |
| Grade 2-vs-Grade 4 |
4.490000E-01 |
| Grade 3-vs-Grade 4 |
6.916200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.77289344000565E-12 |
| Normal-vs-ccB subtype |
1.041410E-04 |
| ccA subtype-vs-ccB subtype |
2.056700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77939999956855E-07 |
| Normal-vs-N1 |
4.843500E-03 |
| N0-vs-N1 |
9.008000E-01 |
|
|
